Dream Finders Homes Buys Beazer Homes in $2.2 Billion Deal, Creating Sixth-Largest U.S. Builder
Dream Finders Homes acquires Beazer Homes for $33.50/share.
NOTRELOAD AI
Why Replimune Shares Dropped Despite FDA Nod for Melanoma Drug TUDRIQEV
Investors reacted to the 24.2% ORR on the official label.
Rockstar Energy Founder Buys $300 Million Stake in Celsius and Offers to Become CEO
Rockstar Energy founder Russ Savage acquires 4.7% of Celsius worth $300M and calls for leadership overhaul after earnings miss, volunteering as CEO.
FDA to Review GRAIL’s Galleri Multi-Cancer Blood Test at September Advisory Meeting
GRAIL’s Galleri cancer blood test will be reviewed by FDA experts as the company seeks full approval for early cancer detection.
Halozyme Delivers Record Quarter, Raises Outlook, and Wins Wall Street Praise
Strong Q2 for Halozyme: Revenue $481M (+48% YoY), royalties +50%. Raises 2026 guidance. H.C. Wainwright, Leerink, Morgan Stanley upgrade.
FDA Completes First-Cycle Review of NRx’s Ketamine ANDA with No Drug-Related Issues
FDA clears path for NRx’s preservative-free ketamine: no major drug issues found, only packaging certification remains.